Ivacaftor decreases monocyte sensitivity to interferon-γ in people with cystic fibrosis.
Katherine B HisertTimothy P BirklandKelly Q SchoenfeltMatthew E LongBrenda GroganSuzanne CarterW Conrad LilesEdward F McKoneLev BeckerAnne M ManiconePublished in: ERJ open research (2020)
This study demonstrates that initiation of the CFTR modulator ivacaftor in people with cystic fibrosis and susceptible CFTR mutations causes an acute reduction in blood monocyte sensitivity to the key proinflammatory cytokine IFN-γ http://bit.ly/2TeI6LG.